Home/Filings/4/0001209191-21-021933
4//SEC Filing

Nolan Mangini Siobhan 4

Accession 0001209191-21-021933

CIK 0001426332other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 8:26 PM ET

Size

8.3 KB

Accession

0001209191-21-021933

Insider Transaction Report

Form 4
Period: 2021-03-17
Nolan Mangini Siobhan
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-03-17+50,00050,000 total
    Exercise: $31.93Exp: 2031-03-16Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the stock option vest over a four-year period commencing January 1, 2021, with 1/48th of the shares vesting on a monthly basis.

Issuer

NGM BIOPHARMACEUTICALS INC

CIK 0001426332

Entity typeother

Related Parties

1
  • filerCIK 0001679464

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 8:26 PM ET
Size
8.3 KB